Quantitative prediction of variant effects on alternative splicing in MAPT using endogenous pre-messenger RNA structure probing

  1. Jayashree Kumar
  2. Lela Lackey
  3. Justin M Waldern
  4. Abhishek Dey
  5. Anthony M Mustoe
  6. Kevin Weeks
  7. David H Mathews
  8. Alain Laederach  Is a corresponding author
  1. University of North Carolina at Chapel Hill, United States
  2. Clemson University, United States
  3. Baylor College of Medicine, United States
  4. University of Rochester, United States

Abstract

Splicing is highly regulated and is modulated by numerous factors. Quantitative predictions for how a mutation will affect precursor messenger RNA (mRNA) structure and downstream function is particularly challenging. Here we use a novel chemical probing strategy to visualize endogenous precursor and mature MAPT mRNA structures in cells. We used these data to estimate Boltzmann suboptimal structural ensembles, which were then analyzed to predict consequences of mutations on precursor mRNA structure. Further analysis of recent cryo-EM structures of the spliceosome at different stages of the splicing cycle revealed that the footprint of the Bact complex with precursor mRNA best predicted alternative splicing outcomes for exon 10 inclusion of the alternatively spliced MAPT gene, achieving 74% accuracy. We further developed a b-regression weighting framework that incorporates splice site strength, RNA structure, and exonic/intronic splicing regulatory elements capable of predicting, with 90% accuracy, the effects of 47 known and six newly discovered mutations on inclusion of exon 10 of MAPT. This combined experimental and computational framework represents a path forward for accurate prediction of splicing-related disease-causing variants.

Data availability

Sequencing data have been deposited in SRA under BioProject ID PRJNA762079 and PRJNA812003.DMS Reactivities are available as SNRNASMs at https://bit.ly/2WaDw6FAll data generated or analyzed during this study are included in the manuscript and supporting files; Source Data files have been provided for Figures 1,2,4,5 and 6.Modeling and feature generation code is uploaded at https://git.io/JuSW8

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Jayashree Kumar

    Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6914-748X
  2. Lela Lackey

    Department of Genetics and Biochemistry, Clemson University, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Justin M Waldern

    Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Abhishek Dey

    Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Anthony M Mustoe

    Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Kevin Weeks

    Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. David H Mathews

    Department of Biochemistry and Biophysics, University of Rochester, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Alain Laederach

    Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, United States
    For correspondence
    alain@unc.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5088-9907

Funding

National Institutes of Health (R01 HL111527)

  • Alain Laederach

National Institutes of Health (R35 GM 140844)

  • Alain Laederach

National Institutes of Health (R01 GM076485)

  • David H Mathews

National Institutes of Health (R35 GM122532)

  • Kevin Weeks

Cancer Prevention and Research Institute of Texas (CPRIT Scholar)

  • Anthony M Mustoe

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Kumar et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,947
    views
  • 444
    downloads
  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jayashree Kumar
  2. Lela Lackey
  3. Justin M Waldern
  4. Abhishek Dey
  5. Anthony M Mustoe
  6. Kevin Weeks
  7. David H Mathews
  8. Alain Laederach
(2022)
Quantitative prediction of variant effects on alternative splicing in MAPT using endogenous pre-messenger RNA structure probing
eLife 11:e73888.
https://doi.org/10.7554/eLife.73888

Share this article

https://doi.org/10.7554/eLife.73888

Further reading

    1. Computational and Systems Biology
    Junhui Tang, Rui Yang ... Yali Xu
    Research Article

    Individuals residing in plateau regions are susceptible to pulmonary hypertension (PH) and there is an urgent need for a prediction nomogram to assess the risk of PH in this population. A total of 6603 subjects were randomly divided into a derivation set and a validation set at a ratio of 7:3. Optimal predictive features were identified through the least absolute shrinkage and selection operator regression technique, and nomograms were constructed using multivariate logistic regression. The performance of these nomograms was evaluated and validated using the area under the curve (AUC), calibration curves, the Hosmer–Lemeshow test, and decision curve analysis. Comparisons between nomograms were conducted using the net reclassification improvement (NRI) and integrated discrimination improvement (IDI) indices. NomogramI was established based on independent risk factors, including gender, Tibetan ethnicity, age, incomplete right bundle branch block (IRBBB), atrial fibrillation (AF), sinus tachycardia (ST), and T wave changes (TC). The AUCs for NomogramI were 0.716 in the derivation set and 0.718 in the validation set. NomogramII was established based on independent risk factors, including Tibetan ethnicity, age, right axis deviation, high voltage in the right ventricle, IRBBB, AF, pulmonary P waves, ST, and TC. The AUCs for NomogramII were 0.844 in the derivation set and 0.801 in the validation set. Both nomograms demonstrated satisfactory clinical consistency. The IDI and NRI indices confirmed that NomogramII outperformed NomogramI. Therefore, the online dynamic NomogramII was established to predict the risks of PH in the plateau population.

    1. Cancer Biology
    2. Computational and Systems Biology
    Nayoung Kim, Sehhoon Park ... Myung-Ju Ahn
    Research Article

    This study investigates the variability among patients with non-small cell lung cancer (NSCLC) in their responses to immune checkpoint inhibitors (ICIs). Recognizing that patients with advanced-stage NSCLC rarely qualify for surgical interventions, it becomes crucial to identify biomarkers that influence responses to ICI therapy. We conducted an analysis of single-cell transcriptomes from 33 lung cancer biopsy samples, with a particular focus on 14 core samples taken before the initiation of palliative ICI treatment. Our objective was to link tumor and immune cell profiles with patient responses to ICI. We discovered that ICI non-responders exhibited a higher presence of CD4+ regulatory T cells, resident memory T cells, and TH17 cells. This contrasts with the diverse activated CD8+ T cells found in responders. Furthermore, tumor cells in non-responders frequently showed heightened transcriptional activity in the NF-kB and STAT3 pathways, suggesting a potential inherent resistance to ICI therapy. Through the integration of immune cell profiles and tumor molecular signatures, we achieved an discriminative power (area under the curve [AUC]) exceeding 95% in identifying patient responses to ICI treatment. These results underscore the crucial importance of the interplay between tumor and immune microenvironment, including within metastatic sites, in affecting the effectiveness of ICIs in NSCLC.